Records containing: Iron Overload
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-01-31A Phase II Trial of the Safety and Efficacy of Iron Reduction by Phlebotomy in Recipients of Hematopoietic Stem Cell Transplants
-
CLINICAL_TRIALS study record update · 2016-11-17A One-year, Open-label, Single Arm, Multi-center Trial Evaluating the Efficacy and Safety of Oral ICL670 (20 mg/kg/d) in Patients Three to Six Months After Allogeneic Hematopoietic Cell Transplantation in Whom Iron Overload is Present
-
CLINICAL_TRIALS study record update · 2016-10-26The Use of the Calcium Channel Blocker Amlodipine as an Adjuvant Treatment to Iron Chelation for the Prevention of Iron Overload Cardiomyopathy in Patients With Thalassemia
-
CLINICAL_TRIALS study record update · 2016-07-14Observational Study of MRI Monitoring in Patients With Aplastic Anemia (AA) and Low or Int-1 Risk of Myelodysplastic Syndromes(MDS) Complicated With Iron Overload
-
CLINICAL_TRIALS study record update · 2016-06-15Effects of Phlebotomy on Insulin Sensitivity in Insulin Resistance-associated Hepatic Iron Overload Patients
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-04-14ClinicalTrials.gov study NCT00005541
-
CLINICAL_TRIALS study record update · 2015-09-29Multicenter, Open-label, Dose-escalation Study of SP-420 in Subjects With Transfusion-dependent β-Thalassemia
-
CLINICAL_TRIALS study record update · 2015-09-09Amlodipine in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major: a Randomized, Controlled Trial
-
CLINICAL_TRIALS study record update · 2015-09-01Renal Function Among Thalassemia Patients Treated by a Oral Chelator Deferasirox
-
CLINICAL_TRIALS study record update · 2015-04-21Influence of Iron Depletion by Phlebotomy on the Risk of Hepatocellular Carcinoma Occurrence in Patients With Compensated Alcoholic Cirrhosis. Prospective, Multicentre, Randomized Trial
-
CLINICAL_TRIALS study record update · 2014-11-13Iron Homoeostasis in Inflammation: A Single Center Observational Cross-sectional Study
-
CLINICAL_TRIALS study record update · 2014-10-28A Single Arm, Multicenter, Open Label Study of Desferasirox in Chinese Patients With Iron Overload and Aplastic Anemia
-
CLINICAL_TRIALS study record update · 2014-03-04Thalassemia Clinical Research Network (TCRN)
-
CLINICAL_TRIALS study record update · 2013-11-26ClinicalTrials.gov study NCT00000595
-
CLINICAL_TRIALS study record update · 2013-06-11Effectiveness of Deferasirox Therapy on Comprehensive Management of Iron Overload in Adult and Pediatric Transfusion-dependent Patients: a Long Term Retrospective Study
-
CLINICAL_TRIALS study record update · 2012-05-21Cytochrome P450 2E1 and Iron Overload
-
CLINICAL_TRIALS study record update · 2012-05-01Open-Label Single-Arm Pilot Study of Deferasirox (Exjade®) in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients With Transfusional Iron Overload
-
CLINICAL_TRIALS study record update · 2012-02-09Compassionate Use of Deferiprone in Patients With Thalassemia and Iron-Induced Heart Disease
-
CLINICAL_TRIALS study record update · 2011-08-26Clinical and Laboratory Assessment of Iron Overload in Sickle Cell Anemia and Sickle Cell Thalassemia Using T2* Cardiac MRI.
-
CLINICAL_TRIALS study record update · 2011-07-291-year Extension to CICL670A2402 an Open-label, Multi-center Trial of the Efficacy and Safety of Long-term Treatment With Deferasirox (10 to 20 mg/kg/Day) in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2- Year Duration)
-
CLINICAL_TRIALS study record update · 2011-06-14Efficacy and Safety of Desferal Versus Osveral in Transfusional Iron Overload Patients With β-Thalassemia and Intermediate Thalassemia in Bandarabbas
-
CLINICAL_TRIALS study record update · 2011-05-18A Phase I/II Open Label, Dose Escalation Trial and a Six Month Extension to Explore the Safety and Efficacy of ICL670 in Patients With Iron Overload Resulting From Hereditary Hemochromatosis.
-
CLINICAL_TRIALS study record update · 2011-05-02A Randomized, Open-label, Multi-center, Phase II Study to Evaluate the Safety and Efficacy of Deferasirox (ICL670) 20 mg/kg/Day Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients With Iron Overload From Repeated Blood Transfusions
-
CLINICAL_TRIALS study record update · 2010-07-26Assessment of Iron Deposition in Major Organs of Hemodialysis Patients, Using T2*MRI and Novel Biomarkers of Free Iron Species
-
CLINICAL_TRIALS study record update · 2010-05-12Fetal Parenchymatic Evaluation (Liver, Spleen) Using T2* Sequences.